小分子
淋巴瘤
靶向治疗
化学
药理学
医学
癌症研究
计算生物学
生物
癌症
生物化学
免疫学
内科学
作者
Zhonghui Wang,Xiang Zheng,Guo‐Wu Rao,Quan Zheng
标识
DOI:10.1080/17568919.2024.2359893
摘要
Lymphoma, a blood tumor, has become the ninth most common cancer in the world in 2020. Targeted inhibition is one of the important treatments for lymphoma. At present, there are many kinds of targeted drugs for the treatment of lymphoma. Studies have shown that Histone deacetylase, Bruton's tyrosine kinase and phosphoinositide 3-kinase all play an important role in the occurrence and development of tumors and become important and promising inhibitory targets. This article mainly expounds the important role of these target protein in tumors, and introduces the mechanism of action, structure-activity relationship and clinical research of listed small molecule inhibitors of these targets, hoping to provide new ideas for the treatment of lymphoma.
科研通智能强力驱动
Strongly Powered by AbleSci AI